Therma Bright (TSE:THRM) has released an update.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Therma Bright Inc. has announced that its Venowave VW5 device received a permanent HCPCS code from the Centers for Medicare and Medicaid Services, enabling reimbursement for patients. The device, addressing a range of circulatory issues including DVT, now offers both purchase and rental options with capped reimbursement rates. This marks a significant advancement for the company, which aligns with the growing market for DVT treatments projected to reach $1.5 billion by 2032.
For further insights into TSE:THRM stock, check out TipRanks’ Stock Analysis page.
